Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

v3.8.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
 3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Total Net Revenue $ 1,605,196 $ 1,913,227
Total Cost of Sales 1,054,234 1,038,063
Gross Profit 550,962 875,164
Operating Expenses:    
Research and development 438,780 378,456
Selling, general and administrative 1,276,903 1,769,693
Depreciation and amortization 16,915 9,909
Total Operating Expenses 1,732,598 2,158,058
Operating loss (1,181,636) (1,282,894)
Other (Expenses) Income:    
Interest (expense), net (2,530) (10,353)
Total Other (Expense) (2,530) (10,353)
Loss from Continuing Operations Before Provision (Benefit) for Income Taxes (1,184,166) (1,293,247)
Provision for Income Taxes 991
Net Loss from Continuing Operations (1,184,166) (1,294,238)
Discontinued Operations:    
Gain from sale of discontinued operations (net of tax) 0 6,384,871
Income from discontinued operations (net of tax) 0 571,802
Net Income (loss) attributable to common stockholders $ (1,184,166) $ 5,662,435
Net income (loss) per common share:    
Basic - continuing operations $ (0.01) $ (0.01)
Basic - discontinued operations 0.05
Basic - net income (loss) attributable to common stockholders (0.01) 0.04
Diluted - continuing operations (0.01) (0.01)
Diluted - discontinued operations 0.05
Diluted - net income (loss) attributable to common stockholders $ (0.01) $ 0.04
Weighted Average Common Shares Outstanding used in computing basic net loss per share 133,695,111 132,774,475
Weighted Average Common Shares Outstanding used in computing diluted net loss per share 133,695,111 133,520,471
Product [Member]    
Total Net Revenue $ 1,503,658 $ 1,810,385
Total Cost of Sales 994,237 1,008,045
Recurring [Member]    
Total Net Revenue 101,538 102,842
Total Cost of Sales $ 59,997 $ 30,018